A draft of the new International Consensus Guideline on Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD), designed […]
BOSTON—Extended-duration prophylactic therapy with letermovir (Prevymis, Merck) may reduce cytomegalovirus (CMV) reactivation in allogeneic hematopoietic stem cell […]